percentage of americans taking glp 1 Some 22% American women and 14% of men have taken GLP-1s for weight loss or for chronic conditions such as diabetes. In charts we show the social and economic effects: bit.ly/44MJFWn Poll: 1 in 8 Adults

With BrightTrack, we hope to give everyone the tools they need to stay consistent, understand their own progress, and feel supported on their journey."

Scientific Publication Patterns by Theme The scientific literature from 2020 through 2025 reveals parallel trends, with publication volume concentrated in areas that mirror patent activity

In SURMOUNT-1, tirzepatide at 515 mg once weekly produced even greater average weight loss in adults with obesity.[2] By contrast, structured research on true microdosing regimens is limited

We identified six biophysical properties that can be predicted from a sequence using the ProtParam module ( from the biopython Python package 45 : (1) the isoelectric point in neutral pH, (2) GRAVY (grand average of hydropathy) 46 , (3) the instability index 47 , (4) aromaticity, (5) the molar extinction coefficient and (6) molecular weight